Ghana Pharmaceuticals & Healthcare Q4 2019
The actions of the National Medicine Price Committee will primarily benefit individual patients and institutional payers inGhana's pharmaceutical market. It will also provide some benefits to pharmaceutical companies operating in the country. A cap onpatented drug prices will, however, not be welcomed by foreign multinationals. Drugmakers should be aware that the Ghanaian cediwill see greater volatility in the short term.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook